Serial Number | 97927270 |
Word Mark | INTYMA SHOT |
Filing Date | Tuesday, May 9, 2023 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Monday, May 20, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders |
NOT AVAILABLE | "SHOT" |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, May 15, 2023 |
Primary Code | 005 |
First Use Anywhere Date | Sunday, April 9, 2023 |
First Use In Commerce Date | Sunday, April 9, 2023 |
Party Name | Intyma, LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Miami, FL 33176 |
Event Date | Event Description |
Friday, May 12, 2023 | NEW APPLICATION ENTERED |
Monday, May 15, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Friday, February 2, 2024 | ASSIGNED TO EXAMINER |
Friday, February 2, 2024 | NON-FINAL ACTION WRITTEN |
Friday, February 2, 2024 | NON-FINAL ACTION E-MAILED |
Friday, February 2, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, May 20, 2024 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Monday, May 20, 2024 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |